Antibiotic trial aims to slash stillbirths in west africa
NCT ID NCT03909737
First seen Nov 01, 2025 · Last updated Jun 06, 2026 · Updated 38 times
Summary
This large study in Mali tests whether giving the antibiotic azithromycin to pregnant women and their newborns can prevent stillbirths and infant deaths. Over 99,000 participants are involved, comparing the antibiotic to a placebo during routine care. The goal is to find a simple, low-cost way to reduce high mortality rates in one of the world's most vulnerable regions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STILLBIRTHS AND INFANT MORTALITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre pour le Developpement des Vaccins - Mali
Bamako, Mali
Conditions
Explore the condition pages connected to this study.